MedPath

The efficacy of GLP-1 receptor agonist on glycemic control in type 2 diabetes with inadequate DPP-4 inhibitor therapy.

Not Applicable
Conditions
type 2 diabetes
Registration Number
JPRN-UMIN000006959
Lead Sponsor
Department of Metabolism and Endocrinology, Juntendo Graduate University of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Not provided

Exclusion Criteria

1)patients who come under contraindicaion for GLP-1 receptor agonist. 2) patients who come under careful administration for GLP-1 receptor agonist 3)patients with cancer 4)anemic patients (Hb is less than 11g/dL) 5) patients with thrombocytepenia (Platelet count is less than 100000/mm3) 6) patients with serious diabetic complications including progressed neutopathy and proliferative retinopathy 7) patietns with serious infection, inflammation, or injuary. pre- or post- operative state 8) patients who are pregnant, hope to be pregnant, or are in lactation period 9) patients who are not applicable to this study judged by the medical doctor.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath